Role of Reactive Oxygen Species in the Abrogation of Oxaliplatin Activity by Cetuximab in Colorectal Cancer.
about
p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the StoryCetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study.Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer TherapyDihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma.N-myc downstream-regulated gene 1 promotes oxaliplatin-triggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2.New strategies in esophageal carcinoma: promises and problems.Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer.ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.Induction of reactive oxygen species: an emerging approach for cancer therapy.Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway.The hepatoprotective role of reduced glutathione and its underlying mechanism in oxaliplatin-induced acute liver injury.HER4 isoform CYT2 and its ligand NRG1III are expressed at high levels in human colorectal cancer.Putting a brake on stress signaling: miR-625-3p as a biomarker for choice of therapy in colorectal cancer.Panitumumab in combination with modified docetaxel/cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group
P2860
Q26742078-C95A53D8-3093-4347-99C1-69E8B442CCB1Q33829760-5EB69D19-91D2-406F-8CDC-74D75482F81DQ33862425-25126CE2-8DE3-436F-8A27-73EC15223D46Q37644922-5A007996-BB82-4CAA-99C7-BF04D8B5BB12Q38767402-D566356E-FBAE-40AA-A91D-4377F759B45EQ39717218-35C0FD50-9348-4775-8F77-138434DEFC22Q40129598-7B4CBB71-21C5-4209-A220-9C279D00AB62Q46255272-4D72EE64-E36C-474C-9CE9-4840B4468B0BQ46302962-258EE222-7608-4E6E-9586-B9D3F748BBBBQ47133723-C5B1122A-AC7F-4F8C-89A9-EA67B942D975Q49292463-82B27443-C9A4-4B8F-8EE8-08F3FF71FFEFQ52608458-850418C6-19E6-404A-AA61-ADA6BF79751CQ53762655-795556B8-A1F7-485A-B181-8B9C2FBDB1AAQ58541804-5A864DEE-C375-40B5-B436-4E09E81ADA2B
P2860
Role of Reactive Oxygen Species in the Abrogation of Oxaliplatin Activity by Cetuximab in Colorectal Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Role of Reactive Oxygen Specie ...... etuximab in Colorectal Cancer.
@en
type
label
Role of Reactive Oxygen Specie ...... etuximab in Colorectal Cancer.
@en
prefLabel
Role of Reactive Oxygen Specie ...... etuximab in Colorectal Cancer.
@en
P2093
P2860
P356
P1476
Role of Reactive Oxygen Specie ...... etuximab in Colorectal Cancer.
@en
P2093
Andrew R Silver
Anke Nijhuis
Daniel Hochhauser
Hannah Thompson
John A Hartley
Konstantinos Kiakos
Rosemary Jeffery
Ruochen Jia
Valeria Santoro
P2860
P304
P356
10.1093/JNCI/DJV394
P407
P577
2015-06-01T00:00:00Z